Events

ICT 2022 – The 16th International Congress of Toxicology

This event is jointly organised by the International Union of Toxicology (IUTOX) and the European Society of Toxicology and will take place in Maastricht, the Netherlands, from September 18-21, 2022. The event hopes to unite the best toxicological scientists worldwide in the historical city of Maastricht.

We hope to see you there!

AASLD 2022 – The Liver Meeting

This year’s AASLD Conference will discuss the latest research on disease states like NAFLD, NASH, and Hepatitis. While educational sessions from leading hepatologists and public health experts will run alongside. Or delve deep with a niche session from one of the leading minds in the Meet-the-Expert sessions. The patient’s perspective will also be presented by the Patient Advocacy Group programming.

Will you be there too?

Every Breath You Take – Predicting Inhaled Drug ADME Using Lung-on-a-Chip

Our lungs provide a large surface area for absorption, access to the whole blood volume and comparatively little metabolic activity. These factors make the administration of drugs via inhalation into the lungs superior to many other methods. Emily discusses the lack of in vitro models and how our Lung-on-a-Chip technologies look to bridge the gap.

Bringing Life to PK Profiles

In Vivo-Relevance From an In Vitro Environment. In this webinar, we will introduce a new MPS platform designed to address these challenges: the PhysioMimix™ PK – a novel microformulator developed by CN Bio.

Formulating a New Approach to Pharmacokinetics and Cell State Control

Understand the biological implications of sequential batch feeding of cells in conventional in vitro experiments.

Pathologically Scarred by Fibrosis:

How To Model and Quantify Human NASH in a Microphysiological System. Non-alcoholic steatohepatitis (NASH) is a widespread disease affecting up to ~12% of the US population – characterized by lipid accumulation in hepatocytes, infiltration of immune cells and fibrosis of the liver. Replicating liver fibrosis is a key element in any in vitro NASH model, however, it is normally poorly assessed, unquantifiable and has a limited dynamic range.

Towards a Body-on-a-Chip:

The Value of Multi-Organ MPS for Human-Relevant Drug Assessment. Join Dr Tomasz Kostrzewski, Director of Biology at CN Bio for a brand new webinar exploring how single and multi-organ MPS can be incorporated into your drug discovery and development workflows to increase translation of pre-clinical assays.

Engineering Mucosal Barriers

From Organoids to Organs-on-Chips with Professor Linda Griffith, S.E.T.I. Professor of Biological and Mechanical Engineering Research
Director of the Center for Gynepathology Research at MIT

A Microphysiological Model of Metastatic Progression

Using systems to model metastatic progression. Join Dr Amanda Clark, Research Assistant Professor at University of Pittsburgh.

Testing on Humans

How to Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using Liver-on-a-Chip. Join Dr Tomasz Kostrzewski, Director of Biology at CN Bio

The Rhythm of Life

Using Microfluidics To Mimic Blood Flow in Single- and Multi-Organ-on-a-Chip Models. Join Dr Graham Broder, Associate Director Engineering and Alysha Bray, Scientist at CN Bio.

A Regulators Viewpoint

Establishing Strategies To Evaluate Microphysiological Systems for Drug Development. Join Dr Alexandre Ribeiro, Staff Fellow (Biological Scientist) at the FDA.

Go with the Flow

Application of Microfluidic 3D Liver Chip Models To Genotoxicity Testing. Join Dr Renato Cardoso, Scientific Director of Genetic Toxicology and Dr Thalita Zanoni, Senior Research Scientist at Charles River Laboratories (Montreal – Canada)

The Scars of Fat

The Transability of 3D NASH Microtissues To Model Human/murine NASH. Join Dr Michele Vacca, Clinical Research Associate Institute of Metabolic Science, TVP Lab at University of Cambridge

An Introduction to Organ-On-a-Chip

The Future of Pre-clinical Drug Research. Join Vaish Manoharan, Account Manager at CN Bio.